Oppenheimer & Co’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,450
Closed -$271K 1409
2023
Q3
$271K Buy
+14,450
New +$243K 0.01% 1161
2021
Q4
Sell
-14,430
Closed -$135K 1516
2021
Q3
$135K Buy
+14,430
New +$114K ﹤0.01% 1434

Other funds holding FRO

Oppenheimer & Co's FRO Position: Q4 2023 in Review

Oppenheimer & Co sold out of Frontline (FRO) in Q4 2023, closing a stake of 14,450 shares — an estimated $271K sold.

Oppenheimer & Co first reported a position in FRO in Q3 2021 and held it in 2 quarters. The position peaked at $271K in Q3 2023. 179 funds tracked by Wall St. Rank hold FRO as of Q4 2023.

  • Oppenheimer & Co reported no remaining Frontline position as of Q4 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 14,450 Frontline shares in Q4 2023, an estimated $271K.
  • Oppenheimer & Co first reported a position in Frontline in Q3 2021 and held it in 2 quarters.
  • Oppenheimer & Co's Frontline position peaked at $271K in Q3 2023.
  • 179 funds tracked by Wall St. Rank held Frontline as of Q4 2023.

Based on Oppenheimer & Co's 13F filing for Q4 2023, filed 13 Feb 2024.